Home
Vanta Bioscience Ltd PE Ratio

Vanta Bioscience Ltd
NSE: VANTABIOSCIENCE
PE
Key Highlights
- The P/E Ratio of Vanta Bioscience Ltd is 0 as of 22 Apr 9.00 AM .
- The P/E Ratio of Vanta Bioscience Ltd changed from 57.2 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
- The Latest Trading Price of Vanta Bioscience Ltd is ₹ 22.99 as of 21 Apr 15:30 .
- The PE Ratio of FMCG Industry has changed from 52.0 to 80.0 in 5 years. This represents a CAGR of 9.00%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of FMCG industry is 80.0. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Vanta Bioscience Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Vanta Bioscience Ltd
Company Fundamentals for Vanta Bioscience Ltd

Vanta Bioscience Ltd
NSE: VANTABIOSCIENCE
Share Price
Market Price of Vanta Bioscience Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Apr 2025 | 22.99 |
16 Apr 2025 | 24.2 |
15 Apr 2025 | 23.05 |
11 Apr 2025 | 21.96 |
09 Apr 2025 | 20.92 |
08 Apr 2025 | 19.94 |
07 Apr 2025 | 20.96 |
04 Apr 2025 | 22.06 |
03 Apr 2025 | 23.22 |
28 Mar 2025 | 22.12 |
BlinkX Score for Vanta Bioscience Ltd
Asset Value vs Market Value of Vanta Bioscience Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Vanta Bioscience Ltd | 14.51 | - |
Hindustan Unilever Ltd | 552154 | 53.3 |
Nestle India Ltd | 231345 | 73.6 |
Varun Beverages Ltd | 184853 | 69.8 |
Britannia Industries Ltd | 129861 | 59.7 |
Godrej Consumer Products Ltd | 124178 | 72.0 |
Company | |
---|---|
Vanta Bioscience Ltd | 14.51 |
Hindustan Unilever Ltd | 552154 |
Nestle India Ltd | 231345 |
Varun Beverages Ltd | 184853 |
Britannia Industries Ltd | 129861 |
Godrej Consumer Products Ltd | 124178 |
PE Ratio of Vanta Bioscience Ltd Explained
₹14.51
Market cap
₹-3
Earnings
0.0X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of FMCG Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Vanta Bioscience Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Vanta Bioscience Ltd
Historical Revenue, EBITDA and Net Profit of Vanta Bioscience Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Vanta Bioscience Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Vanta Bioscience Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Vanta Bioscience Ltd
About Vanta Bioscience Ltd
- Vanta Bioscience Limited was originally incorporated as a Private Limited Company on 29th April 2016 with the name 'Vanta Bioscience Private Limited'.
- The Company converted into a Public Limited Company and the name was changed to 'Vanta Bioscience Limited' on 17th March 2017. The Company is presently engaged in the business of Preclinical Activities.
- The Company provides risk assessment services for evaluating safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of product. The Company is established as a center of excellence for GLP toxicology and safety assessment offering services in India and across the globe.
- One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world.
Vanta Bioscience Ltd News Hub
Vanta Bioscience to hold board meeting
Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 6 December 2024 Pow
Read more
04 Dec 24
Vanta Bioscience to declare Quarterly Result
Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 14 November 2024 Po
Read more
12 Nov 24
Vanta Bioscience schedules EGM
Vanta Bioscience announced that an Extra Ordinary General Meeting (EGM) of the Company will be held
Read more
10 Dec 24